期刊文献+

质子泵抑制剂三联疗法治疗十二指肠球部溃疡的效果观察 被引量:1

Effect observation of triple therapy of proton pump inhibitors treating duodenal bulbar ulcer
下载PDF
导出
摘要 目的研究质子泵抑制剂三联疗法治疗十二指肠球部溃疡的效果。方法选择80例经胃镜检查确诊Hp阳性的十二指肠球部溃疡患者,随机分为A组40例、B组40例,A组用兰索拉唑30 mg,qd×4周,克拉霉素0.5 g,bid×1周,阿莫西林1.0 g,bid×1周;B组用法莫替丁20 mg,bid×4周,克拉霉素0.5 g,bid×1周,阿莫西林1.0 g,bid×1周。疗程(4周)结束后,复查胃镜并做14C呼气试验及快速尿素酶试验,比较两组的溃疡愈合率、Hp根除率。结果 A、B组的溃疡愈合率分别为95.0%、82.5%,Hp根除率为92.5%、70.0%。A、B两组的溃疡愈合率、Hp根除率比较,差异有统计学意义(P<0.05)。结论兰索拉唑三联疗法能有效根除Hp,是治疗十二指肠球部溃疡比较理想的方法。 Objective To study the effect of triple therapy of proton pump inhibitors treating duodenal bulbar ulcer. Methods 80 patients with duodenal bulbar ulcer confirmed with Hp positive by gastroscope examination were selected and randomly divided into the group A (n=40) and the group B (n=40).The group A were treated by lansoprazole 30 mg once daily for four weeks,clarithromycin 0.5 g twice daily for one week, and amoxicillin 1.0 g twice daily for one week;while the group B were treated by famotidine 20 mg twice daily for four weeks and the same usage of clarithromycin and amoxicillin.After completion of treatment course (four weeks),gastroscope examination and C14 expiratory test and rapid urease test were conducted,the rate of HP eradicating and ulcer healing of the two groups were compared. Results The rate of ulcer healing in the group A and the group B was 95.0% and 82.5% respectively,and the rate of Hp eradicating was 92.5% and 70.0% respectively,and there was a statistical difference of the rate of Hp eradicating and ulcer healing in the two groups (P〈0.05). Conclusion Lansoprazole triple therapy can effectively eradicate Hp,and it is an ideal method for treating duodenal bulbar ulcer.
出处 《中国当代医药》 2013年第28期76-77,共2页 China Modern Medicine
关键词 兰索拉唑 法莫替丁 十二指肠球部溃疡 幽门螺杆菌 Lansoprazole Famotidine Duodenal bulbar ulcer Helicobacter pylori
  • 相关文献

参考文献6

二级参考文献27

  • 1湛先保,李兆申,程能能,杜奕奇,邹多武,尹宁,龚燕芳.埃索美拉唑对健康志愿者抑制胃泌酸的药效学研究[J].中华消化杂志,2004,24(12):711-714. 被引量:21
  • 2王震华,熊光苏,吴叔明.埃索美拉唑和奥美拉唑联合抗生素根除幽门螺杆菌疗效对比:荟萃分析[J].胃肠病学,2006,11(10):598-601. 被引量:6
  • 3吴茂平.雷贝拉唑三联对幽门螺杆菌的疗效观察[J].临床和实验医学杂志,2007,6(2):134-134. 被引量:4
  • 4Castell DO, Kahrilas PJ, Richter JE, et al. Esomeprazole ( 40 mg ) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis [J]. Am J Gastroentero1,2002,97 ( 3 ) :575 - 583.
  • 5Talley NJ, Lauritsen K, Tunturi - Hihnala H, et al. Esomeprazole 20 mg maintains symptom control in endoscopy - negative gastrooesophageal reflux disease:a controlled trial of“on - demand” therapy for 6 months [J]. Aliment Pharmacol Ther,2001,15 (3) : 347 - 354.
  • 6Wong BC,Wang WI,Yoe YK. Rabeprazole based 3 day and 7 day triple therapy for the treatment of Helicobacter pyori infection [J]. Aliment Pharmacol Ther,2001,15(12) :1959-1965.
  • 7Malfertheiner P,Megraud F,O' Morain C,et al.Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000Consensus Report[J].Aliment Pharmacol Ther,2002,16(2):167-180.
  • 8Heep M,Kist M,Strobel S,et al.Secondary resistance among 554isolates of Helicobacter pylori after failure of therapy[J].Eur J Clin Microbiol Infect Dis,2000,19(7):538-541.
  • 9Antos D,Schneider-Brachert W,Bastlein E,et al.7-day triple therapy of helieobacter pylori infection with levofloxacin,amoxicillin and highdose esomprazole in patients with known antimicrobial sensitivity[J].Helicobacter,2006,11(1):39-45.
  • 10牛春燕,罗金燕,木尼拉,王学勤.CYP2C19基因多态性与质子泵抑制剂对消化性溃疡患者抑酸效应的关系[J].世界华人消化杂志,2007,15(19):2151-2155. 被引量:25

共引文献46

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部